This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


2vip

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
[[Image:2vip.jpg|left|200px]]
[[Image:2vip.jpg|left|200px]]
-
{{Structure
+
<!--
-
|PDB= 2vip |SIZE=350|CAPTION= <scene name='initialview01'>2vip</scene>, resolution 1.72&Aring;
+
The line below this paragraph, containing "STRUCTURE_2vip", creates the "Structure Box" on the page.
-
|SITE= <scene name='pdbsite=AC1:Act+Binding+Site+For+Chain+A'>AC1</scene>, <scene name='pdbsite=AC2:So4+Binding+Site+For+Chain+A'>AC2</scene> and <scene name='pdbsite=AC3:L1r+Binding+Site+For+Chain+A'>AC3</scene>
+
You may change the PDB parameter (which sets the PDB file loaded into the applet)
-
|LIGAND= <scene name='pdbligand=ACT:ACETATE+ION'>ACT</scene>, <scene name='pdbligand=L1R:4-(2-AMINOETHOXY)-3,5-DICHLORO-N-[3-(1-METHYLETHOXY)PHENYL]BENZAMIDE'>L1R</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene>
+
or the SCENE parameter (which sets the initial scene displayed when the page is loaded),
-
|ACTIVITY= <span class='plainlinks'>[http://en.wikipedia.org/wiki/U-plasminogen_activator U-plasminogen activator], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.21.73 3.4.21.73] </span>
+
or leave the SCENE parameter empty for the default display.
-
|GENE=
+
-->
-
|DOMAIN=
+
{{STRUCTURE_2vip| PDB=2vip | SCENE= }}
-
|RELATEDENTRY=[[2viv|2VIV]], [[1c5x|1C5X]], [[1gj9|1GJ9]], [[2vio|2VIO]], [[1w0z|1W0Z]], [[1fv9|1FV9]], [[1vja|1VJA]], [[1gj8|1GJ8]], [[1w11|1W11]], [[1sqo|1SQO]], [[1gjd|1GJD]], [[1w10|1W10]], [[1owk|1OWK]], [[1w12|1W12]], [[1gi9|1GI9]], [[1o5a|1O5A]], [[1c5z|1C5Z]], [[1owj|1OWJ]], [[1gi7|1GI7]], [[1o5b|1O5B]], [[1gjc|1GJC]], [[1sc8|1SC8]], [[1gja|1GJA]], [[1o3p|1O3P]], [[1owe|1OWE]], [[1sqa|1SQA]], [[1gjb|1GJB]], [[2viw|2VIW]], [[1f92|1F92]], [[1owi|1OWI]], [[1kdu|1KDU]], [[2vin|2VIN]], [[1sqt|1SQT]], [[1f5l|1F5L]], [[1owd|1OWD]], [[1ejn|1EJN]], [[2viq|2VIQ]], [[1lmw|1LMW]], [[1u6q|1U6Q]], [[1gi8|1GI8]], [[2jde|2JDE]], [[1c5y|1C5Y]], [[1w14|1W14]], [[1vj9|1VJ9]], [[1w13|1W13]], [[1gj7|1GJ7]], [[1c5w|1C5W]], [[1owh|1OWH]], [[1o5c|1O5C]]
+
-
|RESOURCES=<span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2vip FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2vip OCA], [http://www.ebi.ac.uk/pdbsum/2vip PDBsum], [http://www.rcsb.org/pdb/explore.do?structureId=2vip RCSB]</span>
+
-
}}
+
'''FRAGMENT-BASED DISCOVERY OF MEXILETINE DERIVATIVES AS ORALLY BIOAVAILABLE INHIBITORS OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR'''
'''FRAGMENT-BASED DISCOVERY OF MEXILETINE DERIVATIVES AS ORALLY BIOAVAILABLE INHIBITORS OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR'''
Line 36: Line 33:
[[Category: Vinkovic, M.]]
[[Category: Vinkovic, M.]]
[[Category: Wallis, N G.]]
[[Category: Wallis, N G.]]
-
[[Category: blood coagulation]]
+
[[Category: Blood coagulation]]
-
[[Category: egf-like domain]]
+
[[Category: Egf-like domain]]
-
[[Category: fibrinolysis]]
+
[[Category: Fibrinolysis]]
-
[[Category: glycoprotein]]
+
[[Category: Glycoprotein]]
-
[[Category: hydrolase]]
+
[[Category: Hydrolase]]
-
[[Category: inhibitor]]
+
[[Category: Inhibitor]]
-
[[Category: kringle]]
+
[[Category: Kringle]]
-
[[Category: pharmaceutical]]
+
[[Category: Pharmaceutical]]
-
[[Category: phosphorylation]]
+
[[Category: Phosphorylation]]
-
[[Category: plasminogen activation]]
+
[[Category: Plasminogen activation]]
-
[[Category: polymorphism]]
+
[[Category: Polymorphism]]
-
[[Category: protease]]
+
[[Category: Protease]]
-
[[Category: secreted]]
+
[[Category: Secreted]]
-
[[Category: serine protease]]
+
[[Category: Serine protease]]
-
[[Category: urokinase-type plasminogen activator]]
+
[[Category: Urokinase-type plasminogen activator]]
-
[[Category: zymogen]]
+
[[Category: Zymogen]]
-
 
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May 4 18:52:57 2008''
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Mar 31 05:12:47 2008''
+

Revision as of 15:52, 4 May 2008

Image:2vip.jpg

Template:STRUCTURE 2vip

FRAGMENT-BASED DISCOVERY OF MEXILETINE DERIVATIVES AS ORALLY BIOAVAILABLE INHIBITORS OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR


Overview

Fragment-based lead discovery has been applied to urokinase-type plasminogen activator (uPA). The (R)-enantiomer of the orally active drug mexiletine 5 (a fragment hit from X-ray crystallographic screening) was the chemical starting point. Structure-aided design led to elaborated inhibitors that retained the key interactions of (R)-5 while gaining extra potency by simultaneously occupying neighboring regions of the active site. Subsequent optimization led to 15, a potent, selective, and orally bioavailable inhibitor of uPA.

About this Structure

2VIP is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.

Reference

Fragment-based discovery of mexiletine derivatives as orally bioavailable inhibitors of urokinase-type plasminogen activator., Frederickson M, Callaghan O, Chessari G, Congreve M, Cowan SR, Matthews JE, McMenamin R, Smith DM, Vinkovic M, Wallis NG, J Med Chem. 2008 Jan 24;51(2):183-6. Epub 2007 Dec 29. PMID:18163548 Page seeded by OCA on Sun May 4 18:52:57 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/2vip"
Personal tools